The American Journal of Managed Care

319. ash.confex.com/ash/2018/webprogram/Paper112214.html. 2. Dr David L. Porter discusses side effects of CAR T-cell therapy. The American Journal of Managed Care® website. ajmc.com/interviews/dr-david-l-porter-discusses-side-effects-ofcar-t-cell-therapy. Published April 11, 2017. Accessed December 2, 2018. 3. Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell non-Hodgkin Lymphoma (TRANSCEND-NHL-001). clinicaltrials.gov/ct2/show/NCT02631044. Updated October 12, 2018. December 2, 2018. 4. Resource use management: principles 6-10. Global Health Cost Consortium website. ghcosting.org/pages/standards/principles/resource_use_measurement. 5. Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome [erratum in Blood. 2015;126(8):1048]. Blood. 2014;124(2):188-195. doi: 10.1182/blood-2014-05-552729. Length of Hospital Stay Key Driver of Costs Associated With CRS Following CAR T-Cell Treatment Surabhi Dangi-Garimella, PhD